Madrigal Pharmaceuticals (MDGL) PT Raised to $174 at B.Riley/FBR
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: MDGL) | Delayed: 396.32 -34.84 (8.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $431.16 | 52 Week High | $18.24 | |||
| Open | $449.32 | 52 Week Low | $6.60 | |||
| Day High | $482.73 | P/E | N/A | |||
| Day Low | $387.33 | EPS | $0.00 | |||
| Volume | 1,979,194 | |||||
